References: Principles of treating psychoses including schizophrenia in adults and young people

  • Austin M-P, Highet N, and the Expert Working Group. Mental health care in the perinatal period: Australian clinical practice guideline. Melbourne: Centre of Perinatal Excellence; 2017. https://www.cope.org.au/health-professionals/health-professionals-3/review-of-new-perinatal-mental-health-guidelines/
  • Ceraso A, Lin JJ, Schneider-Thoma J, Siafis S, Tardy M, Komossa K, et al. Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev 2020;8:CD008016. https://www.ncbi.nlm.nih.gov/pubmed/32840872
  • Early Psychosis Guidelines Writing Group; EPPIC National Support Program. Australian clinical guidelines for early psychosis. 2nd update ed. Melbourne: Orygen, the National Centre of Excellence in Youth Mental Health; 2016. https://www.orygen.org.au/Training/Resources/Psychosis/Clinical-practice-points/Australian-Clinical-Guidelines-for-Early-Psychosis
  • Findling RL, Cavus I, Pappadopulos E, Vanderburg DG, Schwartz JH, Gundapaneni BK, et al. Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study. J Child Adolesc Psychopharmacol 2013;23(8):531–44. https://www.ncbi.nlm.nih.gov/pubmed/24111983
  • Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry 2016;50(5):410–72. https://www.ncbi.nlm.nih.gov/pubmed/27106681
  • Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia. Part 3: Update 2015 management of special circumstances: Depression, suicidality, substance use disorders and pregnancy and lactation. World J Biol Psychiatry 2015;16(3):142–70. https://www.ncbi.nlm.nih.gov/pubmed/25822804
  • Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol 2010;24(4 Suppl):81–90. https://www.ncbi.nlm.nih.gov/pubmed/20923923
  • Krause M, Zhu Y, Huhn M, Schneider-Thoma J, Bighelli I, Chaimani A, et al. Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis. Eur Neuropsychopharmacol 2018;28(6):659–74. https://www.ncbi.nlm.nih.gov/pubmed/29802039
  • Lambert TJ, Reavley NJ, Jorm AF, Oakley Browne MA. Royal Australian and New Zealand College of Psychiatrists expert consensus statement for the treatment, management and monitoring of the physical health of people with an enduring psychotic illness. Aust N Z J Psychiatry 2017;51(4):322–37. https://www.ncbi.nlm.nih.gov/pubmed/28343435
  • McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. J Psychopharmacol 2017;31(5):519–52. https://www.ncbi.nlm.nih.gov/pubmed/28440103
  • Seeman MV, Ross R. Prescribing contraceptives for women with schizophrenia. J Psychiatr Pract 2011;17(4):258–69. https://www.ncbi.nlm.nih.gov/pubmed/21775827
  • Shimomura Y, Kikuchi Y, Suzuki T, Uchida H, Mimura M, Takeuchi H. Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms. Schizophr Res 2020;215:8–16. https://www.ncbi.nlm.nih.gov/pubmed/31784340
  • Ten Velden Hegelstad W, Haahr U, Larsen TK, Auestad B, Barder H, Evensen J, et al. Early detection, early symptom progression and symptomatic remission after ten years in a first episode of psychosis study. Schizophr Res 2013;143(2-3):337–43. https://www.ncbi.nlm.nih.gov/pubmed/23219862
  • Tiihonen J, Tanskanen A, Taipale H. 20-year nationwide follow-up study on discontinuation of antipsychotic treatment in first-episode schizophrenia. Am J Psychiatry 2018;175(8):765–73. https://www.ncbi.nlm.nih.gov/pubmed/29621900
  • Whitworth AB. Psychopharmacological treatment of schizophrenia during pregnancy and lactation. Curr Opin Psychiatry 2017;30(3):184–90. https://www.ncbi.nlm.nih.gov/pubmed/28306564
  • Zipursky RB, Menezes NM, Streiner DL. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review. Schizophr Res 2014;152(2-3):408–14. https://www.ncbi.nlm.nih.gov/pubmed/23972821